Private Trust Company’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Private Trust Company’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-250	Closed	-$17K	–	2322
2022 Q3	$17K	Hold	250	–	–	﹤0.01%	1261
2022 Q2	$8K	Buy	+250	New	+$7.32K	﹤0.01%	1608

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Trust Company's GBT Position: Q4 2022 in Review

Private Trust Company sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 250 shares — an estimated $17K sold.

Private Trust Company first reported a position in GBT in Q2 2022 and held it in 2 quarters. The position peaked at $17K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Private Trust Company reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Private Trust Company sold 250 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $17K.
Private Trust Company first reported a position in Global Blood Therapeutics, Inc. in Q2 2022 and held it in 2 quarters.
Private Trust Company's Global Blood Therapeutics, Inc. position peaked at $17K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Private Trust Company's 13F filing for Q4 2022, filed 18 Jan 2023.